Table 5.

Results of application to Trial of Preventing Hypertension dataset.

		Scenario 1						Scenario 2
	Quantity	${\psi }_{\mathit{SP}13}$	95% CI	${\psi }_{\mathit{SP}123}$	95% CI	$s$	95% CI	${\psi }_{\mathit{SP}13}$	95% CI	${\psi }_{\mathit{SP}123}$	95% CI	$s$	95% CI
Sex	Female	0.99	(0.99, >0.99)	0.99	(0.99, >0.99)	1.0	(−147.2, 138.6)	0.92	(0.89, 0.94)	0.96	(0.93, 0.98)	0.9	(−140.9, 130.1)
	Male	0.99	(0.99, >0.99)	0.99	(0.99, >0.99)	1.4	(−164.8, 154.9)	0.94	(0.92, 0.95)	0.97	(0.95, 0.98)	1.6	(−120.9, 98.1)
Age	<50	0.99	(0.96, >0.99)	0.99	(0.99, >0.99)	−0.9	(−80.7, 74.6)	0.99	(0.96, >0.99)	0.99	(0.99, >0.99)	−0.3	(−143.3, 138.0)
	>50	0.99	(0.99, >0.99)	0.99	(0.99, >0.99)	2.9	(−139.0, 127.7)	0.99	(0.95, >0.99)	0.99	(0.98, >0.99)	1.8	(−132.7, 125.2)